lissamine rhodamine b has been researched along with Bladder Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, J; Sun, X; Yan, X; Yuan, X; Zhao, H; Zheng, Q | 1 |
| Barrios, CH; Battastini, AM; Bertola, G; Dietrich, F; Figueiró, F; Gerhardt, D; Moreira Fonseca, JC; Morrone, FB; Salbego, CG; Zanotto-Filho, A | 1 |
| Amadori, D; Fabbri, F; Frassineti, GL; Gasperi Campani, A; Gunelli, R; Ricotti, L; Tesei, A; Ulivi, P; Zoli, W | 1 |
| Banasiak, D; Barnetson, AR; Mameghan, H; Odell, RA; Russell, PJ | 1 |
4 other study(ies) available for lissamine rhodamine b and Bladder Cancer
| Article | Year |
|---|---|
Licochalcone A inhibiting proliferation of bladder cancer T24 cells by inducing reactive oxygen species production.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Chalcones; Dose-Response Relationship, Drug; Fluoresceins; Glutathione; Glycyrrhiza; Humans; Oxidative Stress; Plant Extracts; Reactive Oxygen Species; Rhodamines; Urinary Bladder Neoplasms | 2014 |
Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3β.
Topics: Antineoplastic Agents; Apoptosis; Aporphines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Extracellular Signal-Regulated MAP Kinases; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Peumus; Plant Extracts; Proto-Oncogene Proteins c-akt; Rhodamines; Signal Transduction; Tetrazolium Salts; Thiazoles; Urinary Bladder Neoplasms | 2014 |
Schedule-dependent cytotoxic interaction between epidoxorubicin and gemcitabine in human bladder cancer cells in vitro.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Division; Cell Line, Tumor; Clinical Trials as Topic; Comet Assay; Deoxycytidine; DNA Damage; Dose-Response Relationship, Drug; Drug Synergism; Epirubicin; Flow Cytometry; Gemcitabine; Humans; Inhibitory Concentration 50; Mutation; Rhodamines; Time Factors; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms | 2004 |
Comparison between the clonogenic, MTT, and SRB assays for determining radiosensitivity in a panel of human bladder cancer cell lines and a ureteral cell line.
Topics: Cell Survival; Dose-Response Relationship, Radiation; Humans; Radiation Tolerance; Rhodamines; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Stem Cell Assay; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1999 |